Central calcium and cannabinoid signaling
中枢钙和大麻素信号传导
基本信息
- 批准号:8236613
- 负责人:
- 金额:$ 29.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAdverse effectsAffectAgonistAnimal ModelAntiepileptic AgentsAreaBehavioralBindingBinding SitesBiological AssayBrainCNR1 geneCNR2 geneCalciumCalcium-Sensing ReceptorsCannabinoidsCannabisCationsCellsChronicChronic Cancer PainClinical effectivenessCollaborationsCoupledDataDiseaseDissectionDose-LimitingDrug AddictionDrug DesignDrug usageEndocannabinoidsEnvironmentExcitatory SynapseG-Protein-Coupled ReceptorsGilles de la Tourette syndromeHuntington DiseaseKnowledgeLigandsLightLinkMarijuana DependenceMeasuresMovement DisordersMuscleMutant Strains MiceMutationNeocortexNerveNervous system structureNeurologicNeuronsNucleus solitariusPatch-Clamp TechniquesPathway interactionsPeripheralPharmaceutical PreparationsProbabilityProtein IsoformsReceptor ActivationResearchSignal TransductionSliceSpasmSpinal cord injurySynaptic TransmissionSynaptic plasticitySystemTestingThinkingTransfectionTranslatingWorkaddictionanandamidebasecannabinoid receptorchronic paindesignextracellularfight againstimprovedinterestmutantnervous system disorderneuronal excitabilitynovelnovel strategiesoverexpressionpatch clampreceptorreceptor functionreceptor structure functionreceptor-mediated signalingresearch studyresponsevoltagewasting
项目摘要
DESCRIPTION (provided by applicant): Cannabis is the most widely used illegal drug and it has been linked with numerous serious adverse effects. Cannabis has also been proposed as useful therapy for several neurological conditions including chronic pain, AIDS-related muscle wasting, and movement disorders. Detailed knowledge about the mechanisms by which this drug acts is crucial to understanding its many effects, and may greatly assist in the design of drugs to facilitate treatment of cannabis dependence and the above diseases. In addition to the two well-characterized classical cannabinoid receptors three other receptors have recently been identified. Based on the distribution and function in the brain of the extracellular Ca-sensing receptor (CaSR) it has been suggested that it a potential target for cannabinoids. In preliminary experiments we found that cannabinoids activate CaSR, a G-protein coupled receptor (GPCR), localized in the majority of nerve terminals in the brain, and activation of CaSR modulates synaptic transmission. These preliminary findings, coupled with the abundance of CaSR in the brain, may fundamentally change our understanding of the mechanisms of cannabinoid action. The objective of this proposal is to determine if CaSR is an important pathway in the action of cannabinoids and whether brain CaSR is activated directly by cannabinoids. We are ideally suited to perform this project because of our expertise in CaSR function in nerve terminals and expression systems. Successful completion of these specific aims will characterize the response of CaSR to cannabinoids, shedding light on the broader range of influence of CaSR and substantially change the thinking in this field. Our rationale is that the identification and characterization of a novel and prevalent cannabinoid receptor will facilitate our understanding of the behavioral actions of the commonly used drug cannabis. Moreover, distinguishing the various actions of cannabinoids may translate into the identification of a novel class of drugs that facilitate treatment of cannabis addiction and several neurological diseases.
PUBLIC HEALTH RELEVANCE: Cannabis is a commonly used drug that is associated with drug dependence, but has also been proposed as therapy for several illnesses including chronic pain, cancer and AIDS-related wasting. New improved treatments are needed but this requires improved understanding of how cannabis works. We have discovered a new pathway in the brain that is activated by cannabis-like drugs. By studying this new pathway we will discover more about how cannabis works and so improve the chances of designing new treatments to help in the fight against drug dependence and many serious diseases.
描述(由申请人提供):大麻是使用最广泛的非法药物,它与许多严重的不良反应有关。大麻也被提议作为几种神经系统疾病的有效治疗方法,包括慢性疼痛,艾滋病相关的肌肉萎缩和运动障碍。详细了解这种药物的作用机制对于了解其许多作用至关重要,并可能大大有助于设计药物以促进大麻依赖和上述疾病的治疗。除了两种典型的大麻素受体外,最近还鉴定了另外三种受体。基于细胞外钙敏感受体(CaSR)在脑中的分布和功能,已表明它是大麻素的潜在靶点。在初步实验中,我们发现大麻素激活CaSR,这是一种G蛋白偶联受体(GPCR),位于大脑中的大多数神经末梢中,CaSR的激活调节突触传递。这些初步发现,加上大脑中丰富的CaSR,可能会从根本上改变我们对大麻素作用机制的理解。该提案的目的是确定CaSR是否是大麻素作用的重要途径,以及大脑CaSR是否直接被大麻素激活。我们非常适合执行这个项目,因为我们在神经末梢和表达系统中的CaSR功能方面的专业知识。这些具体目标的成功完成将表征CaSR对大麻素的反应,揭示CaSR更广泛的影响范围,并大大改变这一领域的思维。我们的理由是,一种新的和普遍的大麻素受体的鉴定和表征将有助于我们了解常用药物大麻的行为作用。此外,区分大麻素的各种作用可能会转化为识别一类新的药物,有助于治疗大麻成瘾和几种神经系统疾病。
公共卫生相关性:大麻是一种与药物依赖有关的常用药物,但也被提议用于治疗多种疾病,包括慢性疼痛,癌症和艾滋病相关的消耗。需要新的改进治疗方法,但这需要更好地了解大麻的作用机制。我们在大脑中发现了一条新的通路,它被大麻类药物激活。通过研究这一新途径,我们将更多地了解大麻的作用机制,从而提高设计新疗法的机会,以帮助对抗药物依赖和许多严重疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen M Smith其他文献
Valproic acid and HIV-1 latency: beyond the sound bite
丙戊酸和 HIV-1 潜伏期:超越原话
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:3.3
- 作者:
Stephen M Smith - 通讯作者:
Stephen M Smith
Comprehensive Molecular Characterization of Polymorphous Adenocarcinoma, Cribriform Subtype: Identifying Novel Fusions and Fusion Partners.
多形性腺癌,筛状亚型的综合分子特征:识别新的融合和融合伴侣。
- DOI:
10.1016/j.modpat.2023.100305 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
E. Hahn;Bin Xu;N. Katabi;S. Dogan;Stephen M Smith;B. Perez–Ordoñez;Paras B. Patel;Christina MacMillan;Daniel J. Lubin;J. Gagan;I. Weinreb;J. Bishop - 通讯作者:
J. Bishop
New York City HIV superbug: fear or fear not?
纽约市艾滋病毒超级细菌:恐惧还是不恐惧?
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:3.3
- 作者:
Stephen M Smith - 通讯作者:
Stephen M Smith
Studying neuroanatomy using MRI
使用磁共振成像研究神经解剖学
- DOI:
10.1038/nn.4501 - 发表时间:
2017-02-23 - 期刊:
- 影响因子:20.000
- 作者:
Jason P Lerch;André J W van der Kouwe;Armin Raznahan;Tomáš Paus;Heidi Johansen-Berg;Karla L Miller;Stephen M Smith;Bruce Fischl;Stamatios N Sotiropoulos - 通讯作者:
Stamatios N Sotiropoulos
Stephen M Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen M Smith', 18)}}的其他基金
Equipment Supplement: Sodium Channel Control of Neuronal Excitability
装备补充:钠通道控制神经元兴奋性
- 批准号:
10382711 - 财政年份:2020
- 资助金额:
$ 29.26万 - 项目类别:
Dynamic Chemical Regulation of Voltage-gated Sodium Channels
电压门控钠通道的动态化学调节
- 批准号:
10266071 - 财政年份:2015
- 资助金额:
$ 29.26万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 29.26万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 29.26万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 29.26万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 29.26万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 29.26万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 29.26万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 29.26万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 29.26万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 29.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 29.26万 - 项目类别:
Standard Grant